References
- Fineberg HV, Hiatt HH. Evaluation of medical practices. The case for technology assessment. N Engl J Med 1979; 301: 1086–91.
- Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. J Am Med Assoc 1995; 274: 645–51.
- McAlister FA, Straus SE, Sackett DL. Why we need large, simple studies of the clinical examination: the problem and a proposed solution. CARE-COAD1 group. Clinical Assessment of the Reliability of the Examination – Chronic Obstructive Airways Disease Group. Lancet 1999; 354: 1721–4.
- Begg CB. Experimental design of medical imaging trials. Issues and options. Invest Radiol 1989; 24: 934–6.
- Moons CKGM. Hazards of univariable approach in diagnostic test evaluation in Diagnostic Research Theory and Application. PhD Thesis 1996: 37–52.
- Khan KS, Chien PF, Dwarakanath LS. Logistic regression models in obstetrics and gynecology literature. Obstet Gynecol 1999; 93: 1014–20.
- Gupta JK, Chien PF, Khan KS. The diagnostic accuracy of endometrial thickness measurement by pelvic ultrasonography in predicting endometrial hyperplasia/carcinoma in women with postmenopausal bleeding: a metaanalysis. Acta Obstet Gynecol Scand 2002; 81: 799–816.
- Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. J Am Med Assoc 2002; 288: 1610–21.
- Bakour SH, Khan KS, Newton JR. Evaluation of the endometrium in abnormal uterine bleeding associated with long-term tamoxifen use. Gynaecol Endosc 2000; 9: 19–22.
- Bakour SH, Dwarakanath LS, Khan KS, Newton JR, Gupta JK. The diagnostic accuracy of ultrasound scan in predicting endometrial hyperplasia and cancer in postmenopausal bleeding. Gynaecol Endosc 1999; 8: 143–8.
- Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. J Am Med Assoc 1998; 280: 1510–17.
- Ben Yehuda OM, Kim YB, Leuchter RS. Does hystero- scopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma? Gynecol Oncol 1998; 68: 4–7.
- Cicinelli E, Comi N, Scorcia P, Petruzzi D, Epifani S. Hysteroscopy for diagnosis and treatment of endometrial adenocarcinoma precursors. A review of literature. Eur J Gynaecol Oncol 1993; 14: 425–36.
- Uno LH, Sugimoto O, Carvalho FM, Bagnoli VR, Fonseca AM, Pinotti JA. Morphologic hysteroscopic criteria suggestive of endometrial hyperplasia. Int J Gynaecol Obstet 1995; 49: 35–40.
- Clark TJ, Mann CH, Song F, Khan KS, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia: a systematic quantitative review. Acta Obstet Gynecol Scand 2001; 80: 784–93.
- Clark TJ, Mann CH, Shah N, Song F, Khan KS, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. Br J Obstet Gynaecol 2002; 109: 313–21.
- Rothman KJ, Greenland S. Modern Epidemiology, 2nd ed. Lippincot Williams & Wilkins, Philadelphia, 1998.
- Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285–93.
- Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29–36.
- Irwig L, Macaskill P, Glasziou P, Fahey M. Metaanalytic methods for diagnostic test accuracy. J Clin Epidemiol 1995; 48: 119–30.
- Walter SD, Jadad AR. Meta-analysis of screening data: a survey of the literature. Stat Med 1999; 18: 3409–24.
- Linnet K. A review on the methodology for assessing diagnostic tests. Clin Chem 1988; 34: 1379–86.
- Tosteson AN, Weinstein MC, Wittenberg J, Begg CB. ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment. Environ Health Perspect 1994; 102: 73–8.
- Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med 1980; 302: 1109–17.
- Jain MG, Rohan TE, Howe GR. Hormone replacement therapy and endometrial cancer in Ontario, Canada. J Clin Epidemiol 2000; 53: 385–91.
- Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergstrom R, Lindgren A et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 1999; 91: 1131–7.
- Clark TJ, Bakour SH, Gupta JK, Khan KS. Evaluation of outpatient hysteroscopy and ultrasonography in the diagnosis of endometrial disease. Obstet Gynecol 2002; 99: 1001–7.